Do you want to read an article? Please log in or register.
Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET
Lung, Respiratory and Thoracic Cancer
Related content
Breast Cancer
Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer
Cancer Res.
Gulbahce N, Magbanua MJM, Chin R, Agarwal MR, Luo X, Liu J, Hayden DM, Mao Q, Ciotlos S, Li Z, Chen Y, Chen X, Li Y, Zhang RY, Lee K, Tearle R, Park E, Drmanac S, Rugo HS, Park JW, Drmanac R, Peters BA
doi: 10.1158/
Lung, Respiratory and Thoracic Cancer
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI
Clin Drug Investig.
Mann H, Andersohn F, Bodnar C, Mitsudomi T, Mok TSK, Yang JC, Hoyle C
doi: 10.1007/s40261-017-0611-3.
Endocrine and Neuroendocrine Tumors (NET)Genitourinary Cancer
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis
Eur J Cancer
Wenzel M, Deuker M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Becker A, Roos FC, Chun FKH, Karakiewicz PI
doi: 10.1016/j.ejca.2021.07.014
Genitourinary CancerRadio-Oncology
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer
Eur Urol.
Spratt DE, Dess RT, Zumsteg ZS, Lin DW, Tran PT, Morgan TM6, Antonarakis ES, Nguyen PL, Ryan CJ, Sandler HM3, Cooperberg MR, Posadas E, Feng FY
doi: 10.1016/j.eururo.2017.06.027.
Lung Cancer
Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations.
1Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Head and Neck CancerRadio-Oncology
Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of 18F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting
Radiother Oncol.
van den Bosch S, Dijkema T, Philippens MEP, Terhaard CHJ, Hoebers FJP, Kaanders JHAM, Oyen WJG
doi: 10.1016/j.radonc.2018.06.037.
Lung, Respiratory and Thoracic Cancer
Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients
ESMO Open
Rothschild SI, Nachbur R, Herzog N, Passweg JR, Pless M
doi: 10.1016/j.esmoop.2020.100013
Breast Cancer
18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis
Breast Cancer Res.
Groheux D, Martineau A, Teixeira L, Espié M, de Cremoux P, Bertheau P, Merlet P, Lemarignier C
doi: 10.1186/
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
J Thorac Oncol
Wu YL, John T, Grohe C, Majem M, Goldman JW, Kim SW, Kato T, Laktionov K, Vu HV, Wang Z, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Atasoy A, Herbst RS, Tsuboi M
doi: 10.1016/j.jtho.2021.10.014